Skip to content
value.today

Foundation Medicine, Inc.

🇺🇸 Boston, Massachusetts, USABiotechnologyFounded 2009

Formerly Foundation Genomics, Inc.

Total raised
$73 M
3 rounds on record
Latest round
$56 M
Sep 2012
First round on record
Mar 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Foundation Medicine, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2012$56 MNo. 3$50 to $250 million

Foundation Medicine, Inc.: Raise no. 3, Sep 2012

Investors in this round

22 investors had bought by the notice of Jan 10, 2013: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Foundation Medicine, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$56 M of $56 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason W. Ryan · Executive Officer
  • Kevin W. Krenitsky · Executive Officer
  • Michael J. Pellini · Executive Officer, Director
  • Robert W. Hesslein · Executive Officer
  • Alexis W. Borisy · Director
  • Brook W. Byers · Director
  • David W. Schenkein · Director
  • Evan W. Jones · Director
  • Krishna W. Yeshwant · Director
  • Mark W. Levin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Hesslein, Senior VP and General Counsel. Source: SEC Form D and 1 amendment, newest notice filed Jan 10, 2013. Read the notice at the SEC.

equitySEC
Aug 2011$10 MNo. 2$10 to $50 million

Foundation Medicine, Inc.: Raise no. 2, Aug 2011

Investors in this round

1 investor had bought by the notice of Aug 23, 2011: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Foundation Medicine, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $21 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin Krenitsky, M.D. · Executive Officer
  • Michael Pellini, M.D. · Executive Officer, Director
  • Alexis Borisy, M.S. · Director
  • David Schenkein · Director
  • Mark Levin · Director
  • Robert Tepper, M.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jason Ryan, Treasurer. Source: SEC Form D, newest notice filed Aug 23, 2011. Read the notice at the SEC.

equitySEC
Mar 2010$7 MNo. 1$2 to $10 million

Foundation Medicine, Inc.: Raise no. 1, Mar 2010

Investors in this round

1 investor had bought by the notice of Apr 15, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Foundation Medicine, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $25 M offered; $18 M still to sell
Smallest investment taken
$7,000,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$35,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexis Borisy · Executive Officer, Director · Alexis Borisy, M.S., President
  • Mark Levin · Director
  • Robert Tepper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter B. Finn, Assistant Secretary and General Counsel. Source: SEC Form D, newest notice filed Apr 15, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Foundation Medicine, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2013).

    SEC Form D · Jan 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2013

That is all the official record says: Foundation Medicine, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

7 named in official filings. Open an investor to see everything it has backed.

Investors in Foundation Medicine, Inc.
InvestorKindAmountRoundRoleSource
Google Ventures 2011, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
Kleiner Perkins Caufield & Byers XIV, LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
KPCB XIV Associates, LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
KPCB XIV Founders Fund, LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
Third Rock Ventures GP, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
Third Rock Ventures LPVenture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
TRV GP, LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2013)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Foundation Medicine, Inc.
NameRoleNamed in
Jason W. RyanExecutive officerJan 2013
Kevin W. KrenitskyExecutive officerJan 2013
Michael J. PelliniExecutive officerJan 2013
Robert W. HessleinExecutive officerJan 2013
Kevin Krenitsky, M.D.Executive officerAug 2011
Michael Pellini, M.D.Executive officerAug 2011
Alexis BorisyAlexis Borisy, M.S., PresidentApr 2010
Alexis W. BorisyDirectorJan 2013
Brook W. ByersDirectorJan 2013
David W. SchenkeinDirectorJan 2013
Evan W. JonesDirectorJan 2013
Krishna W. YeshwantDirectorJan 2013
Mark W. LevinDirectorJan 2013
Michael J. PelliniDirectorJan 2013
Alexis Borisy, M.S.DirectorAug 2011
David SchenkeinDirectorAug 2011
Mark LevinDirectorAug 2011
Michael Pellini, M.D.DirectorAug 2011
Robert Tepper, M.D.DirectorAug 2011
Alexis BorisyAlexis Borisy, M.S., PresidentApr 2010
Robert TepperDirectorApr 2010